Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain, Adenocarcinoma of the cervix, Alopecia, Cervix cancer metastatic, Chemotherapy
Clinical narrative: diagnosed with metastatic cervical cancer/adenocarcinoma of the cervix; died due to metastatic cervical cancer/ adenocarcinoma on May 22, 2023/She was in excruciating pain/ abdominal pain, cramping, nausea, vomitting, heavy period, abnormal bleeding; diagnosed with metastatic cervical cancer/adenocarcinoma of the cervix; died due to metastatic cervical cancer/ adenocarcinoma on May 22, 2023/She was in excruciating pain/ abdominal pain, cramping, nausea, vomitting, heavy period, abnormal bleeding; autoimmune injuries; autonomic injuries; neurological injuries; She lost her hair; Her skin became so irritated that, when she was touched, she would cry out in pain; Her skin became so irritated that, when she was touched, she would cry out in pain; Information has been received from a lawyer, regarding a case in litigation and refers to a female patient (pt) of unknown age. The pt's concurrent conditions, medical history and concomitant therapies were not provided. On 17-APR-2014, at the age of 13 years old, the pt was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, lot #, expiration date, route of administration and anatomical location were not provided). On 12-JUN-2014, she received the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, lot #, expiration date, route of administration and anatomical location were not provided). On 09-OCT-2014, the pt received the third dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, lot #, expiration date, route of administration and anatomical location were not provided), all doses were administered for preventing cervical cancer, as recommended by the pt's physician. As a result of receiving human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations, the pt sustained serious and debilitating injuries, including but not limited to autonomic, autoimmune, and neurological injuries and resulting sequalae. On unknown dates, reported as following human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations, the pt experienced abdominal pain, cramping, nausea and vomiting, abnormal bleeding, and heavy periods. On 20-OCT-2019, at the age of 18 years old, she was diagnosed with metastatic cervical cancer/adenocarcinoma of the cervix requiring salpingectomy and bilateral ovarian transposition surgery, chemotherapy and radiation. On an unknown date, the pt's cervical cancer progressed extensively, spreading to her liver, skin, uterus, and eventually lymph node metastases. After each new tumor in a new organ, the pt was treated with a new form of chemotherapy or combination of chemotherapies, and new rounds of stronger radiation. She was in excruciating pain. She lost her hair. Her skin became so irritated that, when she was touched, she would cry out in pain. She required oxycodone and morphine for pain. She was given six months to live and placed in hospice care. On 22-MAY-2023, the pt died of as a result of metastatic cervical cancer/adenocarcinoma. It was unknown if an autopsy was performed. The pt suffered severe physical injuries, and associated symptomology, and suffered severe emotional injuries, including pain and suffering, and wrongful death on 22-MAY-2023. As a direct and proximate result of her human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries and death, the pt suffered considerable non-economic and economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity.The outcome of the events of irritated skin causing pain when touched, losing hair, autonomic, autoimmune, and neurological injuries was not reported. The reporter considered all events to be related to human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  Upon internal review, the events of metastatic cervical cancer/adenocarcinoma and autoimmune disorder were determined to be medically significant.